STAT+: Pharmalittle: FDA is probing J&J Covid-19 vaccine blunder; Fauci says U.S. may not need the AstraZeneca shot
And so, another working week will soon draw to a close. Not a moment too…
Category: Medicine
An antitrust expert weighs in on the FTC’s complaint against Illumina
Spare a thought for Illumina. The $56 billion dollar titan of genomics has become the…
Opinion: Reforming and improving organ transplant systems will save lives, taxpayer dollars
Every day, 33 people — disproportionately people of color — die in the U.S. as…
Opinion: Fee or free? The services hospital-based psychologists provide are ‘priceless’
Hospital-based psychologists are sorely undervalued, not just for the care they provide their patients and…
.jpg)
Virtual therapy startups tackle the gap in mental health care for kids and teens
When Alex Alvarado and his co-founders started their virtual therapy company Daybreak Health in February…
Listen: Talkspace’s civic experiment, Illumina’s FTC headache, & remembering Gilead’s John Martin
Can an app replace in-person therapy? Is Illumina too big to Grail? And is another…
Resistance from health experts and business owners could doom ‘vaccine passports’ even before they launch
WASHINGTON — When it comes to decrying the concept of “vaccine passports,” conservatives have company….
STAT+: FDA is rebuked by a federal agency for downgrading serious concerns over plant inspections
In a stern letter, the U.S. Office of Special Counsel rebuked the Food and Drug…
Why you should get a COVID-19 vaccine – even if you’ve already had the coronavirus
Should you get the vaccine if you’ve already had Covid? Here’s what an expert said….
STAT+: Pharmalittle: 15 million doses of J&J Covid-19 vaccine ruined by ‘human error’; Bristol Myers fights U.S. over a $1.4 billion tax bill
Top of the morning to you. A spot of rain is descending on the Pharmalot…
STAT+: Former Medicare leader Seema Verma joins board of health tech firm Lumeris
She was President Trump’s top Medicare official. Now, Seema Verma, the former Centers for Medicare…
Opinion: MAPGuide: A tool to help improve health-related public-private partnership agreements
Whenever a new infectious outbreak threatens global health, pharmaceutical companies, governments, international organizations, and philanthropies…
STAT+: The health tech tracker for the second quarter: 15 pivotal industry events to watch
Securing a billion dollars of yearly funding was once considered a landmark achievement in health…
STAT+: At BGI, China’s genomics giant, the line between biotech and Beijing is increasingly blurry
On Jan. 25, 2020, as the city of Wuhan headed into the world’s first Covid-19 lockdown,…
Pfizer Announces Positive Results For Teen Covid Vaccine
Early this morning, Pfizer announced results from a phase III trial showing positive results for…
New recalls highlight heart risk of unlisted ingredients
New recalls cover several products that were found to include substances not included on the…
STAT+: The U.S. government doesn’t have patent rights to Gilead’s remdesivir, despite investing millions in research
American taxpayers may have provided $162 million toward researching the drug remdesivir, but the federal…
STAT+: Data for Delcath’s liver tumor device are positive, but lingering questions cloud path to approval
Delcath Systems said Wednesday that its liver-tumor treatment device achieved the primary goal of a…
Opinion: Jason Karlawish and an Alzheimer’s caregiver on dementia’s ripple effect
In this week’s “First Opinion Podcast,” I speak with Alzheimer’s expert Jason Karlawish, director of…
.jpg)
Opinion: In light of anti-Asian attacks, medicine needs to listen to Asian American trainees
The shocking shooting rampage in Atlanta targeting Asian spas, followed not long after by an…
STAT+: Pharmalittle: Pfizer says Covid-19 shot is safe and effective in adolescents; FTC wants to block another Illumina deal
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Pfizer and BioNTech say vaccine prevents Covid-19 in adolescents
Pfizer and BioNTech said Wednesday that their Covid-19 vaccine prevented symptomatic disease and was well-tolerated…
Opinion: A caregiver and physician discuss the financial implications of dementia
In his recent First Opinion, “The long, exhausting reach of dementia care,” Jason Karlawish, a…
Opinion: Vaccination certificates won’t end lockdown. Prosocial approaches will
Covid-19 immunity and vaccination certificates are being held up as golden tickets to the new…
Opinion: Adding social determinants gives public health maps a sense of place and time
Before becoming a public health researcher, I trained as a geologist. That may seem like…
STAT+: The biotech scorecard for the second quarter: 18 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the second…
With light at the end of the tunnel, loved ones feel the anguish of Covid-19 deaths particularly hard
Mark Collins received his Covid-19 vaccine earlier this year through work. His husband, Tony Murray…
Lots of Health Insurance Help in Covid Relief Law — But Do Your Homework First
There’s something for everyone with private health insurance in the American Rescue Plan Act, but…
STAT+: FTC seeks to block Illumina from buying Grail, citing threats to competition
The Federal Trade Commission is once again trying to block Illumina, a dominant maker of…
STAT+: Most U.S. universities get an ‘F’ on ensuring access to drugs they discover
Despite large amounts of taxpayer funding, dozens of the largest U.S. universities failed to commit…
STAT+: STAT+ Conversations: A conversation on the future of gene therapy
Editors note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: Pfizer and BioNTech to boost Covid-19 vaccine production; lawmakers ask FTC to probe insulin pricing
Rise and shine, another busy day is on the way. There is a rhythm to…
A CRISPR 2.0 pioneer, expecting credit on its own invention, is ruffled by a competitor
Last week, the genome-editing scientists behind base editing, a technology dubbed CRISPR 2.0, gathered for…
Opinion: Many hospitalized Covid-19 patients are given antibiotics. That’s a problem
As the Covid-19 pandemic continues into its second year, public health experts are increasingly concerned…
STAT+: 5 health care projects to watch at Google Cloud
If the pieces come together, Google will be as omnipresent in health care as it…
STAT+: Here are the drug pricing policy options Democrats could use to pay for their next big legislative push
WASHINGTON — Democrats in Congress are already gearing up for their next big legislative push,…
Facing data gaps on trans populations, researchers turn to health records for answers
Electronic health records are enabling a new generation of health care researchers to study thousands…
STAT+: The operation formerly known as Warp Speed: Biden leans heavily on the flagship Trump-era initiative
WASHINGTON — The Biden White House has made no secret of its disdain for President…
New CDC study: mRNA vaccines 90% effective
A new study conducted by the CDC offers strong results for mRNA vaccines. Read Original…
Is It Time to Assess the Mental Fitness of Our Presidents?
A psychiatrist argues the need to gauge the mental fitness of future presidents. Read Original…
STAT+: Canadian company pursues compulsory license to distribute Covid-19 vaccine to low-income countries
Twice in recent months, a small Canadian company has approached two large drug makers to…
A Week’s Worth of Recalls
Two drugs, a dietary supplement, and some devices have been recalled for mislabeled dosages, hidden…
STAT+: Humanigen says it drug keeps Covid patients off ventilators. But are some data missing?
A small biotech firm, Humanigen, said Monday that its experimental drug reduced the risk of…
STAT+: Congressional lawmakers urge FTC to investigate insulin makers over their pricing
In the latest flare up over the cost of insulin, several Congressional lawmakers want the…
‘Right now I’m scared’: CDC director warns of a coming spike in Covid-19 case counts
WASHINGTON — As Covid-19 cases begin again to spike throughout the United States, CDC Director…
‘Real world’ study by CDC shows Pfizer and Moderna vaccines were 90% effective
A new study suggests the messenger RNA vaccines produced by Moderna and the Pfizer-BioNTech partnership…
STAT+: Pharmalittle: White House eyes suspending patent rights on Covid-19 vaccines; J&J supplier may be a vaccine bottleneck
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Former top Lilly lobbyist sues the company for alleged sex discrimination and harassment
A former top lobbyist at Eli Lilly (LLY) has filed a lawsuit accusing an executive…
STAT+: Uniqure investigation clears hemophilia B gene therapy as cause of patient’s liver cancer
Uniqure, the Dutch gene therapy company, said Monday that its one-time treatment for hemophilia B…
STAT+: The future of cancer immunotherapy: your questions, answered
Last week, I hosted an hourlong webinar on future directions for cancer immunotherapy. I focused…